The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P

被引:7
|
作者
Zhang, ZQ [1 ]
Schleif, WA [1 ]
Casimiro, DR [1 ]
Handt, L [1 ]
Chen, MC [1 ]
Davies, ME [1 ]
Liang, XP [1 ]
Fu, TM [1 ]
Tang, AM [1 ]
Wilson, KA [1 ]
McElhaugh, M [1 ]
Carella, A [1 ]
Tan, C [1 ]
Connolly, B [1 ]
Hill, S [1 ]
Klein, H [1 ]
Emini, EA [1 ]
Shiver, JW [1 ]
机构
[1] Merck Res Labs, Dept Viral Vaccine Res, West Point, PA 19486 USA
关键词
SHIV; 89.6P; rhesus monkey; viral replication;
D O I
10.1016/j.virol.2003.11.017
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Set-point viral load is positively correlated with the extent of initial viral replication in pathogenic simian-human immunodeficiency virus (SHIV) infection. To elucidate the mechanisms underlying the correlation, we conducted a systematic investigation in rhesus monkeys infected with the highly pathogenic SHIV 89.6P. This model is widely used in the preclinical evaluation of AIDS vaccine candidates and a thorough understanding of the model's biology is important to the proper interpretation of these evaluations. We found that the levels of peak viremia were positively correlated not only with the levels of set-point viremia but, importantly, with the extent of initial overall immune destruction as indicated by the degree of CD4(+) T cell depletion and lymph node germinal center (GC) formation. The extent of initial overall immune destruction was inversely correlated with subsequent development and maintenance of virus-specific cellular and humoral immune responses. Thus, these data suggest that the extent of early immune damage determines the development and durability of virus-specific immunity, thereby playing a critical role in establishing the levels of set-point viral replication in SHIV infection. Vaccines that limit both the initial viral replication and the extent of early immune damage will therefore mediate long-term virus replication control and mitigation of long-term immune destruction in this model of immunodeficiency virus infection.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 50 条
  • [1] Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein
    Silvera, P
    Richardson, MW
    Greenhouse, J
    Yalley-Ogunro, J
    Shaw, N
    Mirchandani, J
    Khalili, K
    Zagury, JF
    Lewis, MG
    Rappaport, J
    JOURNAL OF VIROLOGY, 2002, 76 (08) : 3800 - 3809
  • [2] Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination
    Barouch, DH
    Santra, S
    Kuroda, MJ
    Schmitz, JE
    Plishka, R
    Buckler-White, A
    Gaitan, AE
    Zin, R
    Nam, JH
    Wyatt, LS
    Lifton, MA
    Nickerson, CE
    Moss, B
    Montefiori, DC
    Hirsch, VM
    Letvin, NL
    JOURNAL OF VIROLOGY, 2001, 75 (11) : 5151 - 5158
  • [3] Older rhesus macaque infants are more susceptible to oral infection with simian-human immunodeficiency virus 89.6P than neonates
    Chenine, AL
    Ferrantelli, F
    Hofmann-Lehmann, R
    Vangel, MG
    McClure, HM
    Ruprecht, RM
    JOURNAL OF VIROLOGY, 2005, 79 (02) : 1333 - 1336
  • [4] Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus
    Kumar, R
    Torres, C
    Yamamura, Y
    Rodriguez, I
    Martinez, M
    Staprans, S
    Donahoe, RM
    Kraiselburd, E
    Stephens, EB
    Kumar, A
    JOURNAL OF VIROLOGY, 2004, 78 (20) : 11425 - 11428
  • [5] Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys
    Borsetti, A.
    Baroncelli, S.
    Maggiorella, M. T.
    Bellino, S.
    Moretti, S.
    Sernicola, L.
    Belli, R.
    Ridolfi, B.
    Farcomeni, S.
    Negri, D. R. M.
    Cafaro, A.
    Ensoli, B.
    Titti, F.
    ARCHIVES OF VIROLOGY, 2008, 153 (03) : 463 - 472
  • [6] Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6p challenge in Mamu-A*01-negative rhesus monkeys
    Liang, XP
    Casimiro, DR
    Schleif, WA
    Wang, FB
    Davies, ME
    Zhang, ZQ
    Fu, TM
    Finnefrock, AC
    Handt, L
    Citron, MP
    Heidecker, G
    Tang, AM
    Chen, MC
    Wilson, KA
    Gabryelski, L
    McElhaugh, M
    Carella, A
    Moyer, C
    Huang, LY
    Vitelli, S
    Patel, D
    Lin, J
    Emini, EA
    Shiver, JW
    JOURNAL OF VIROLOGY, 2005, 79 (19) : 12321 - 12331
  • [7] Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines
    Amara, RR
    Villinger, F
    Staprans, SI
    Altman, JD
    Montefiori, DC
    Kozyr, NL
    Xu, Y
    Wyatt, LS
    Earl, PL
    Herndon, JG
    McClure, HM
    Moss, B
    Robinson, HL
    JOURNAL OF VIROLOGY, 2002, 76 (15) : 7625 - 7631
  • [8] Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques
    Bauer, Anya
    Lindemuth, Emily
    Marino, Francesco Elia
    Krause, Ryan F.
    Joy, Jaimy
    Docken, Steffen P.
    Mallick, Suvadip
    McCormick, Kevin M.
    Holt, Clinton J.
    Georgiev, Ivelin A.
    Felber, Barbara C.
    Keele, Brandon A.
    Veazey, Ronald C.
    Davenport, Miles A.
    Li, Hui C.
    Shaw, George A.
    Bar, Katharine C.
    PLOS PATHOGENS, 2023, 19 (07)
  • [9] Persistent babesiosis in a Rhesus macaque ( Macaca mulatta) infected with a simian-human immunodeficiency virus
    Liu, David X.
    Gill, Amy
    Holman, Patricia J.
    Didier, Peter J.
    Blanchard, James L.
    Veazey, Ronald S.
    Lackner, Andrew A.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2014, 43 (03) : 206 - 208
  • [10] Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses
    Reimann, KA
    Watson, A
    Dailey, PJ
    Lin, WY
    Lord, CI
    Steenbeke, TD
    Parker, RA
    Axthelm, MK
    Karlsson, GB
    VIROLOGY, 1999, 256 (01) : 15 - 21